Literature DB >> 32966566

Serum Antibody Profile of a Patient With Coronavirus Disease 2019 Reinfection.

Kelvin Kai-Wang To1,2, Ivan Fan-Ngai Hung3, Kwok-Hung Chan1, Shuofeng Yuan1, Wing-Kin To4, Dominic Ngai-Chong Tsang5, Vincent Chi-Chung Cheng1,2, Zhiwei Chen1, Kin-Hang Kok1, Kwok-Yung Yuen1,2.   

Abstract

We recently reported a patient with coronavirus disease 2019 reinfection. Here, we show that serum neutralizing antibodies could be detected during the first episode but not at the presentation of the second episode. During reinfection, neutralizing antibodies and high avidity immunoglobulin G were found within 8 days after hospitalization, whereas immunoglobulin M response was absent.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibody; immunity; reinfection

Mesh：

Substances：

Year:  2021        PMID： 32966566      PMCID： PMC7543314          DOI： 10.1093/cid/ciaa1368

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  27 in total

1.  SARS-CoV-2 reinfection.

Authors:  I Romera; K Núñez; M Calizaya; I Baeza; R Molina; J Morillas
Journal:  Med Intensiva (Engl Ed)       Date:  2021-02-10

Review 2.  Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.

Authors:  Ramesh Kandimalla; Pratik Chakraborty; Jayalakshmi Vallamkondu; Anupama Chaudhary; Sonalinandini Samanta; P Hemachandra Reddy; Vincenzo De Feo; Saikat Dewanjee
Journal:  Biomedicines       Date:  2021-11-22

3.  Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse.

Authors:  Rohan M Prasad; Shaurya Srivastava; Enhua Wang; Jason Z Liu; Rakesh Gami; Ayat Abdelgadir; Akhil Sharma; Sumugdha Rayamajhi; Richa Tikaria
Journal:  Perm J       Date:  2021-10-29

Review 4.  COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants.

Authors:  Paola Stefanelli; Giovanni Rezza
Journal:  Vaccines (Basel)       Date:  2022-06-06

5.  Dynamic Change and Clinical Relevance of Postinfectious SARS-CoV-2 Antibody Responses.

Authors:  Patrick W G Mallon; Willard Tinago; Alejandro Garcia Leon; Kathleen McCann; Grace Kenny; Padraig McGettrick; Sandra Green; Rosanna Inzitari; Aoife G Cottere; Eoin R Feeney; Stefano Savinelli; Peter Doran
Journal:  Open Forum Infect Dis       Date:  2021-03-26       Impact factor: 3.835

6.  Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Authors:  Yiska Weisblum; Fabian Schmidt; Fengwen Zhang; Justin DaSilva; Daniel Poston; Julio Cc Lorenzi; Frauke Muecksch; Magdalena Rutkowska; Hans-Heinrich Hoffmann; Eleftherios Michailidis; Christian Gaebler; Marianna Agudelo; Alice Cho; Zijun Wang; Anna Gazumyan; Melissa Cipolla; Larry Luchsinger; Christopher D Hillyer; Marina Caskey; Davide F Robbiani; Charles M Rice; Michel C Nussenzweig; Theodora Hatziioannou; Paul D Bieniasz
Journal:  Elife       Date:  2020-10-28       Impact factor: 8.140

7.  A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy.

Authors:  Francesca Bai; Alessandro Tavelli; Giovanni Mulè; Camilla Falcinella; Debora Mondatore; Daniele Tesoro; Diletta Barbanotti; Daniele Tomasoni; Roberto Castoldi; Matteo Augello; Marina Allegrini; Gianmarco Tagliaferri; Andrea Cona; Alessandro Cozzi-Lepri; Giulia Marchetti; Antonella d'Arminio Monforte
Journal:  Front Public Health       Date:  2021-06-10

8.  Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients.

Authors:  Frauke Muecksch; Helen Wise; Becky Batchelor; Maria Squires; Elizabeth Semple; Claire Richardson; Jacqueline McGuire; Sarah Clearly; Elizabeth Furrie; Neil Greig; Gordon Hay; Kate Templeton; Julio C C Lorenzi; Theodora Hatziioannou; Sara Jenks; Paul D Bieniasz
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

Review 9.  The role and uses of antibodies in COVID-19 infections: a living review.

Authors:  D Oliver Scourfield; Sophie G Reed; Max Quastel; Jennifer Alderson; Valentina M T Bart; Alicia Teijeira Crespo; Ruth Jones; Ellie Pring; Felix Clemens Richter; Stephanie E A Burnell
Journal:  Oxf Open Immunol       Date:  2021-01-28

10.  Decline in neutralising antibody responses, but sustained T-cell immunity, in COVID-19 patients at 7 months post-infection.

Authors:  Jun Chen; Xiaomin Liu; Xinyu Zhang; Yixiao Lin; Danping Liu; Jingna Xun; Zhenyan Wang; Ling Gu; Qian Li; Dan Yin; Junyang Yang; Hongzhou Lu
Journal:  Clin Transl Immunology       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.